Olaparib plus paclitaxel plus carboplatin followed by olaparib maintenance treatment in patients with platinum-sensitive recurrent serous ovarian cancer: randomized open-label phase II study - Oza, A (J Clin Oncol, 2012)
(suppl): Abstract